79328112 - GENESYSTEM

Information

  • Trademark
  • 79328112
  • Serial Number
    79328112
  • Registration Number
    7510037
  • Filing Date
    October 25, 2021
    4 years ago
  • Registration Date
    September 24, 2024
    a year ago
  • Transaction Date
    March 23, 2025
    9 months ago
  • Status Date
    September 24, 2024
    a year ago
  • Published for Opposition Date
    July 09, 2024
    a year ago
  • Location Date
    September 23, 2024
    a year ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    FALK,JONATHAN ROBERT
  • Attorney Docket Number
    6794-0134US1
    Attorney Name
    Michael T. Smith
  • Owners
Mark Drawing Code
3
Mark Identification
GENESYSTEM
Case File Statements
  • TL0000: The non-Latin characters in the mark transliterate to the phonetic equivalent to the English phrase "GENE SYSTEM" and this has no meaning in a foreign language.
  • CD0000: The mark consists of the literal elements 'genesystem' and 'genesystem' in Korean, and a design of four bars in front of 'genesystem'. The 'genesystem' and the 'genesystem' in Korean are in GRAY, the first vertical bar is in BLUE, the second vertical short bar next to the first vertical bar is in BLUE, the third vertical bar that bends to the left and bends downward again is in BLUE-GREEN, and the fourth short vertical bar below the third vertical bar is in GREEN.
  • GS0051: Reagent paper for veterinary purposes; reagents for use in veterinary genetic testing; veterinary diagnostic reagents; diagnostic agents for pharmaceutical use; diagnostic test reagents for medical or veterinary purposes; biological and chemical reagents for medical or veterinary purposes; reagents and media for medical and veterinary diagnostic purposes; diagnostic chemical reagents for medical use; diagnostic reagents for medical or veterinary purposes; immunoassay reagents for medical use; biological reagents for medical purposes; reagents for medical use; reagent paper for medical purposes; reagents for use in medical genetic testing; medical diagnostic reagents; chemical test reagents for medical use; clinical diagnostic reagents for medical use; diagnostic biomarker reagents for medical purposes
  • CC0000: The color(s) the colors gray, blue, blue-green and green are claimed as a feature of the mark.
  • GS0011: Diagnostic reagents for scientific or research use; reagents for scientific or medical research use; reagents for analyzing proteins for scientific or laboratory purposes; reagents for nucleic acid amplifications for scientific or laboratory purposes; reagents for extracting proteins for scientific or laboratory purposes; reagents for analyzing nucleic acid for scientific or laboratory purposes; in vitro diagnostic reagents for scientific purposes; antibody reagents for scientific purposes; reagents for scientific purposes for use in nucleic acid isolation and purification; reagents for nucleic acid amplification other than for medical purposes; biological preparations for use in biotechnology other than medical use; reagents for cell straining other than medical use; reagents for cell transformation other than medical use; reagents for research purposes; chemical reagents for use in genetic research; chemical reagents for genetic identity testing; diagnostic reagents, other than for medical or veterinary purposes; reagents for use in scientific apparatus for chemical or biological analysis; protein synthesis chemical reagent other than for medical purposes; chemical reagent for extracting nucleic acid other than for medical purposes
  • DS0000: "GENE SYSTEM" OR THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "GENE SYSTEM"
  • GS0101: genetic testing apparatus for medical purposes; genetic testing apparatus for medical purposes for gene verification; miniaturized sensors for use in gene analysis and diagnosis for medical purposes; real-time gene amplification equipment for medical use; medical genetic fragment analyzers; genetic testing apparatus for medical purposes; medical genetic analyzer; biopsy forceps; diagnostic testing apparatus for medical purposes for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; apparatus for taking blood samples; apparatus for DNA and RNA testing for medical purposes; DNA and RNA extraction and purification apparatus for medical purposes; medical immunoassay apparatus for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; medical instruments for application in human bodies, namely, diagnostic kit comprised of medical diagnostic apparatus for testing for viruses, bacteria, fungi, parasite, rickettsia and protista being a pathogen ; medical apparatus for clinical diagnosis for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; clinical diagnostic kit comprised of test chips for the analysis of body fluids, premix mix, nuclease free water, blood sampling tubes and sealing tapes for testing whole blood, serum, sputum, urine, fecal feces, tissue, cells, DNA and RNA; patient medical monitoring instruments for monitoring DNA amplification results; medical instruments, namely, PCR system comprised of, multiplex biochips for analysis of bodily fluids, diagnostic kit comprised of medical diagnostic apparatus for testing for viruses, bacteria, fungi, parasite, rickettsia and protista being a pathogen, PCR reagents; immunoadsorption columns for medical diagnostic use
  • GS0421: Research and development of DNA chips; DNA screening for scientific research purposes; DNA analysis for scientific research purposes; DNA sequence analysis for scientific research purposes; DNA testing services to determine paternity being laboratory services; providing information relating to scientific analysis of the genetic information via online networks; biological information check being genetic testing for scientific research purposes; biological information check being genetic testing for medical research purposes; research in the field of gene analysis; genetic fingerprinting being DNA analysis services for scientific research purposes; laboratory research in the field of gene expression; scientific research in the fields of biomedicine; consultancy in analysis of biology sequence processing for medical research purposes; biological research; biochemical research; biotechnological research relating to industry; development of biotechnology; research and development of technology for biotechnology; multiple nucleic acid analysis for scientific research purposes; protein analysis being scientific laboratory services
Case File Event Statements
  • 12/9/2021 - 4 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR
  • 12/10/2021 - 4 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 12/14/2021 - 4 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 8/2/2022 - 3 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 8/4/2022 - 3 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 8/5/2022 - 3 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 9/20/2022 - 3 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 9/21/2022 - 3 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 10/10/2022 - 3 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNP
  • 3/4/2023 - 2 years ago
    10 - LIMITATION OF GOODS RECEIVED FROM IB Type: LIMG
  • 3/20/2023 - 2 years ago
    11 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/20/2023 - 2 years ago
    12 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/20/2023 - 2 years ago
    13 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 5/10/2023 - 2 years ago
    14 - NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB Type: OPNR
  • 5/10/2023 - 2 years ago
    15 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 5/11/2023 - 2 years ago
    16 - LIMITATION FROM THE IB - REQUEST EXAM REVIEW Type: LIME
  • 5/30/2023 - 2 years ago
    17 - NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB Type: OPNX
  • 2/6/2024 - a year ago
    18 - FINAL REFUSAL WRITTEN Type: CNFR
  • 2/6/2024 - a year ago
    19 - FINAL REFUSAL E-MAILED Type: GNFR
  • 2/6/2024 - a year ago
    20 - NOTIFICATION OF FINAL REFUSAL EMAILED Type: GNFN
  • 6/4/2024 - a year ago
    22 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 6/4/2024 - a year ago
    23 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 6/4/2024 - a year ago
    21 - TEAS REQUEST FOR RECONSIDERATION RECEIVED Type: ERFR
  • 6/5/2024 - a year ago
    24 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 6/19/2024 - a year ago
    25 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/9/2024 - a year ago
    26 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/9/2024 - a year ago
    27 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 9/24/2024 - a year ago
    28 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/24/2024 - a year ago
    29 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 12/24/2024 - a year ago
    30 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 2/26/2025 - 10 months ago
    31 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 2/27/2025 - 10 months ago
    32 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 3/22/2025 - 9 months ago
    33 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO